Francesca Barone - Dec 8, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Scientific Officer
Signature
/s/ Jason A. Amello, as Attorney-in-Fact for Francesca Barone
Stock symbol
CADL
Transactions as of
Dec 8, 2022
Transactions value $
$1,993
Form type
4
Date filed
12/12/2022, 03:30 PM
Previous filing
Nov 30, 2022
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $1.99K +1.24K +82.53% $1.61 2.74K Dec 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.